Single-inhaler triple therapy in patients with chronic obstructive pulmonary disease: a systematic review
Guidelines recommend that treatment with a long-acting β2 agonist (LABA), a long-acting muscarinic antagonist (LAMA), and inhaled corticosteroids (ICS), i.e. triple therapy, is reserved for a select group of symp...
Source: Respiratory Research - Category: Respiratory Medicine Authors: Sue Langham, Jen Lewis, Nick Pooley, Nina Embleton, Julia Langham, MeiLan K. Han and James D. Chalmers Tags: Review Source Type: research